29
KIT
bigger impact for people living
with diabetes. We completed our
acquisition of Bigfoot Biomedical, a
leader in smart insulin management
systems. Together we'll bring even
more connected solutions for making
diabetes management personal and
precise. Welcome new colleagues
from Bigfoot Biomedical!"
As previously reported, Abbott
and Bigfoot have worked together on
connected diabetes solutions since
2017. Bigfoot have developed Bigfoot
Unity, a smart insulin management
system that features connected
insulin pen caps that use integrated
continuous glucose monitoring
(iCGM) data along with insulin dosing
recommendations displayed on the
pen cap's digital screen. The Bigfoot
Unity system exclusively works with
Abbott's FreeStyle Libre technology,
including FreeStyle Libre 2 sensors
and all major brands of both longacting
(basal) and rapid-acting (bolus)
disposable insulin pens offered in the
United States.
"The acquisition of Bigfoot
Biomedical will combine two leaders
in different aspects of diabetes care:
continuous glucose monitoring and
insulin dosing support," said Jared
Watkin, senior vice president of
Abbott's Diabetes Care business.
"Bringing our companies together
will allow us to further develop
connected solutions for making
diabetes management even more
personal and precise."
"Bigfoot Biomedical is the first
company to design, develop and
deliver a novel insulin delivery
solution built around continuous
glucose monitoring," said Jeffrey
Brewer, chief executive officer,
Bigfoot Biomedical. "We selected
Abbott as our CGM partner because
both companies share a vision to
provide simple, affordable and easyto-use tools for
people with diabetes.
We look forward to continuing
to innovate together and to the
scale Abbott can provide, bringing
Bigfoot Unity to as many people who
may benefit."
Bigfoot's diabetes management
system is designed to address
problems such as missed doses,
inadequate insulin intensification and
dosing errors that affect people with
diabetes who require multiple daily
injections. The system integrates
with Abbott's FreeStyle Libre CGM to
incorporate glucose data and provide
real-time glycaemic alerts.
Dexcom
While there have been no new
launches, Dexcom has been
celebrating five years since
introducing to the world the first
CGM that truly delivered on the
promise of this life-changing
technology with the Dexcom G6
in 2018.
In a blog in its website, the
company states, "Dexcom is a
pioneer in continuous glucose
monitoring (CGM). Since 1999,
we have developed innovative
technology that has transformed
how people manage diabetes.
Our products are part of people's
daily lives, empowering them to
live confidently and feel more in
control, free to pursue their dreams.
Innovating with the times, in line
with advances in other technologies,
is in our DNA as a company.
"When we launched our first
sensor in 2004, iPhones didn't
exist. When we launched our first
sensor that communicated directly
to a smartphone, iPhones still had
home screen buttons, Blackberry
devices still worked, and TikTok